In summary, these results suggest that a further anti-tumor effect of resveratrol is mediated by down-regulation of the CSC signaling pathway and also by inhibition of NF-κB activation in CRC, even in multicellular-TME. The gene discussed is NFKB1; the disease is neoplasm.